MCHR1 and cardiovascular disorder: Compound 512 displayed prominent MCH receptor 1(MCH-R1) binding affinity (IC50 = 1 nM), as well as low human ether-a-go-go-related gene (hERG) binding affinity thereby ensuring low risks of cardiovascular diseases, metabolic stability and preferable pharmacokinetic profile (Lim et al., 2013).